Passage Bio, Inc.PASGNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank29
3Y CAGR-31.0%
5Y CAGR-16.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-31.0%/yr
vs +92.4%/yr prior
5Y CAGR
-16.7%/yr
Recent deceleration
Acceleration
-123.4pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $45.41M | -35.5% |
| 2024 | $70.40M | -27.0% |
| 2023 | $96.42M | -30.3% |
| 2022 | $138.39M | -25.5% |
| 2021 | $185.73M | +64.5% |
| 2020 | $112.90M | +203.6% |
| 2019 | $37.19M | +268.4% |
| 2018 | $10.10M | - |